Revolution sign Tomas Chancalay as a designated player
Forward Tomas Chancalay left his native Argentina to experience the rough and tumble of MLS and decided to stay.
The New England Revolution exercised their permanent transfer option and signed the 24-year-old forward to an MLS contract as a Designated Player through the 2026 season with a one-year club option. Chancalay transferred from Racing Club in Argentina in August.
This was a strategically sound transaction employed by a franchise that has not hired a permanent head coach or sporting director since Bruce Arena resigned both positions in September while under an MLS investigation.
Chancalay debuted on Aug. 26 and quickly became the club’s top scoring option, supplanting Gustavo Bou, and Giacomo Vrioni during a tumultuous phase of the season. Chancalay scored six goals in 11 games that included two braces.
“Thomas performed admirably in his first season in New England and possesses both the natural attacking instincts and technical prowess to be an elite attacking talent in our league,” said Revolution interim sporting director Curt Onalfo.
RICH THOMPSON
More Stories
EU risks investor exodus over Russian assets – Euroclear chief
Plans to tap Moscow’s frozen funds for Ukraine could drive capital out of Europe, Valerie Urbain has warned The EU...
The Russia-China trade paradox the Western media doesn’t bother to explain
A Bloomberg article notes that the yuan share of Russian exports has dropped but that bilateral trade is surging A...
Christmas branded gift orders: working back from Australia Post’s 21 December cut-off
Parcels staying within the same state get one more day, to Tuesday 22 December. Express Post between metro addresses buys...
Laser Welding Safety: Essential Requirements for Industrial Workshops
As manufacturers such as Dynalasers introduce compact air-cooled laser welders for different fabrication needs, proper laser welding safety becomes an...
4 Best Resources for Retatrutide Peptide Research and Clinical Trial Information in 2026
A resource that answers one question well may be the wrong place to answer another. A clinical trial summary cannot...
Mercedes slams brakes on German investment
The auto giant is struggling with high production costs, falling sales in China, and stalled talks over labor cuts German...
